InVivo Therapeutics Holdings Volatility
| NVIVDelisted Stock | USD 1.38 0.07 5.34% |
We have found twenty-nine technical indicators for InVivo Therapeutics, which you can use to evaluate the volatility of the firm. Please check out InVivo Therapeutics' risk adjusted performance of 0.0214, and Market Risk Adjusted Performance of 0.0497 to validate if the risk estimate we provide is consistent with the expected return of 0.0%. Key indicators related to InVivo Therapeutics' volatility include:
90 Days Market Risk | Chance Of Distress | 90 Days Economic Sensitivity |
InVivo Therapeutics Stock volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of InVivo daily returns, and it is calculated using variance and standard deviation. We also use InVivo's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of InVivo Therapeutics volatility.
InVivo |
Since volatility provides investors with entry points to take advantage of stock prices, companies, such as InVivo Therapeutics can benefit from it. Downward market volatility can be a perfect environment for investors who play the long game. Here, they may decide to buy additional stocks of InVivo Therapeutics at lower prices. For example, an investor can purchase InVivo stock that has halved in price over a short period. This will lower your average cost per share, thereby improving your portfolio's performance when the markets normalize. Similarly, when the prices of InVivo Therapeutics' stock rises, investors can sell out and invest the proceeds in other equities with better opportunities. Investing when markets are volatile with better valuations will accord both investors and companies the opportunity to generate better long-term returns.
Moving against InVivo Stock
InVivo Therapeutics Market Sensitivity And Downside Risk
InVivo Therapeutics' beta coefficient measures the volatility of InVivo stock compared to the systematic risk of the entire market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents InVivo stock's returns against your selected market. In other words, InVivo Therapeutics's beta of 1.67 provides an investor with an approximation of how much risk InVivo Therapeutics stock can potentially add to one of your existing portfolios. InVivo Therapeutics Holdings exhibits above-average semi-deviation for your current time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure InVivo Therapeutics' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact InVivo Therapeutics' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.
3 Months Beta |Analyze InVivo Therapeutics Demand TrendCheck current 90 days InVivo Therapeutics correlation with market (Dow Jones Industrial)InVivo Beta |
InVivo standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. A typical volatile entity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.
Standard Deviation | 0.0 |
It is essential to understand the difference between upside risk (as represented by InVivo Therapeutics's standard deviation) and the downside risk, which can be measured by semi-deviation or downside deviation of InVivo Therapeutics' daily returns or price. Since the actual investment returns on holding a position in invivo stock tend to have a non-normal distribution, there will be different probabilities for losses than for gains. The likelihood of losses is reflected in the downside risk of an investment in InVivo Therapeutics.
InVivo Therapeutics Stock Volatility Analysis
Volatility refers to the frequency at which InVivo Therapeutics delisted stock price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with InVivo Therapeutics' price changes. Investors will then calculate the volatility of InVivo Therapeutics' stock to predict their future moves. A delisted stock that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A stock with relatively stable price changes has low volatility. A highly volatile delisted stock is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of InVivo Therapeutics' volatility:
Historical Volatility
This type of delisted stock volatility measures InVivo Therapeutics' fluctuations based on previous trends. It's commonly used to predict InVivo Therapeutics' future behavior based on its past. However, it cannot conclusively determine the future direction of the stock.Implied Volatility
This type of volatility provides a positive outlook on future price fluctuations for InVivo Therapeutics' current market price. This means that the delisted stock will return to its initially predicted market price. This type of volatility can be derived from derivative instruments written on InVivo Therapeutics' to be redeemed at a future date.Transformation |
We are not able to run technical analysis function on this symbol. We either do not have that equity or its historical data is not available at this time. Please try again later.
InVivo Therapeutics Projected Return Density Against Market
Given the investment horizon of 90 days the stock has the beta coefficient of 1.6721 . This indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, InVivo Therapeutics will likely underperform.Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to InVivo Therapeutics or Health Care Equipment & Supplies sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that InVivo Therapeutics' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a InVivo delisted stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
InVivo Therapeutics Holdings has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Predicted Return Density |
| Returns |
What Drives an InVivo Therapeutics Price Volatility?
Several factors can influence a delisted stock's market volatility:Industry
Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.Political and Economic environment
When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.The Company's Performance
Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract many investors to purchase the company. This positive attention will raise the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.InVivo Therapeutics Stock Return Volatility
InVivo Therapeutics historical daily return volatility represents how much of InVivo Therapeutics delisted stock's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The venture inherits 0.0% risk (volatility on return distribution) over the 90 days horizon. By contrast, Dow Jones Industrial accepts 0.7299% volatility on return distribution over the 90 days horizon. Performance |
| Timeline |
About InVivo Therapeutics Volatility
Volatility is a rate at which the price of InVivo Therapeutics or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of InVivo Therapeutics may increase or decrease. In other words, similar to InVivo's beta indicator, it measures the risk of InVivo Therapeutics and helps estimate the fluctuations that may happen in a short period of time. So if prices of InVivo Therapeutics fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.
Please read more on our technical analysis page.InVivo Therapeutics Holdings Corp., a research and clinical-stage biomaterials and biotechnology company, engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries . The company was incorporated in 2003 and is headquartered in Cambridge, Massachusetts. Invivo Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 7 people.
InVivo Therapeutics' stock volatility refers to the amount of uncertainty or risk involved with the size of changes in its stock's price. It is a statistical measure of the dispersion of returns on InVivo Stock over a specified period of time, often expressed as the standard deviation of daily returns. In other words, it measures how much InVivo Therapeutics' price varies over time.
3 ways to utilize InVivo Therapeutics' volatility to invest better
Higher InVivo Therapeutics' stock volatility means that the price of its stock is changing rapidly and unpredictably, while lower stock volatility indicates that the price of InVivo Therapeutics stock is relatively stable. Investors and traders use stock volatility as an indicator of risk and potential reward, as stocks with higher volatility can offer the potential for more significant returns but also come with a greater risk of losses. InVivo Therapeutics stock volatility can provide helpful information for making investment decisions in the following ways:- Measuring Risk: Volatility can be used as a measure of risk, which can help you determine the potential fluctuations in the value of InVivo Therapeutics investment. A higher volatility means higher risk and potentially larger changes in value.
- Identifying Opportunities: High volatility in InVivo Therapeutics' stock can indicate that there is potential for significant price movements, either up or down, which could present investment opportunities.
- Diversification: Understanding how the volatility of InVivo Therapeutics' stock relates to your other investments can help you create a well-diversified portfolio of assets with varying levels of risk.
InVivo Therapeutics Investment Opportunity
Dow Jones Industrial has a standard deviation of returns of 0.73 and is 9.223372036854776E16 times more volatile than InVivo Therapeutics Holdings. Compared to the overall equity markets, volatility of historical daily returns of InVivo Therapeutics Holdings is lower than 0 percent of all global equities and portfolios over the last 90 days. You can use InVivo Therapeutics Holdings to enhance the returns of your portfolios. The stock experiences a very speculative upward sentiment. Check odds of InVivo Therapeutics to be traded at $1.725 in 90 days.Modest diversification
The correlation between InVivo Therapeutics Holdings and DJI is 0.29 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding InVivo Therapeutics Holdings and DJI in the same portfolio, assuming nothing else is changed.
InVivo Therapeutics Additional Risk Indicators
The analysis of InVivo Therapeutics' secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in InVivo Therapeutics' investment and either accepting that risk or mitigating it. Along with some common measures of InVivo Therapeutics stock's risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Risk Adjusted Performance | 0.0214 | |||
| Market Risk Adjusted Performance | 0.0497 | |||
| Mean Deviation | 3.13 | |||
| Semi Deviation | 4.06 | |||
| Downside Deviation | 4.42 | |||
| Coefficient Of Variation | 5514.97 | |||
| Standard Deviation | 4.21 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential stocks, we recommend comparing similar delisted stocks with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
InVivo Therapeutics Suggested Diversification Pairs
Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against InVivo Therapeutics as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. InVivo Therapeutics' systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, InVivo Therapeutics' unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to InVivo Therapeutics Holdings.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Consideration for investing in InVivo Stock
If you are still planning to invest in InVivo Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the InVivo Therapeutics' history and understand the potential risks before investing.
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |